cilomilast has been researched along with Lung Diseases, Obstructive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamant, Z; Spina, D | 1 |
| Barnette, MS; Christensen, SB; Compton, CH; Griswold, DE; Murdoch, RD; Nieman, RB; Torphy, TJ; Underwood, DC | 1 |
| Chapman, R; Fine, J; Jones, H; Kreutner, W; Kung, TT; Minnicozzi, M; Spond, J | 1 |
| Amit, O; Ayres, JG; Bakst, A; Barnes, NC; Brambilla, C; Compton, CH; Creemers, JP; Edelson, J; Gubb, J; Nieman, R; Schultze-Werninghaus, G | 1 |
| Giembycz, MA | 1 |
3 review(s) available for cilomilast and Lung Diseases, Obstructive
| Article | Year |
|---|---|
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
Topics: Aminopyridines; Benzamides; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases, Obstructive; Nitriles; Phosphodiesterase 4 Inhibitors | 2011 |
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.
Topics: Asthma; Cyclohexanecarboxylic Acids; Drug Approval; Humans; Lung Diseases, Obstructive; Nitriles; Phosphodiesterase Inhibitors | 1999 |
Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bronchodilator Agents; Carbon Radioisotopes; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Tolerance; Humans; Lung Diseases, Obstructive; Male; Nitriles; Phosphodiesterase Inhibitors | 2001 |
1 trial(s) available for cilomilast and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Multicenter Studies as Topic; Nitriles; Phosphodiesterase Inhibitors; Quality of Life; Respiratory Function Tests; Surveys and Questionnaires | 2001 |
1 other study(ies) available for cilomilast and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia.
Topics: Adrenalectomy; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Humans; Inflammation; Interleukin-1; Lung Diseases; Lung Diseases, Obstructive; Male; Neutrophils; Nitriles; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Rolipram; Tumor Necrosis Factor-alpha | 2001 |